Zhenyu He

12PUBLICATIONS
43CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 23, 2026
The PDGFB-DDX5 axis contributes to breast cancer radioresistance through HR-associated DNA repair.

|Oct 13, 2026
Radiation-induced AXL upregulation in CCR2+ monocytes promotes cardiac fibrosis.

|Dec 04, 2025
Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progression of Breast Cancer.

Yixin Cheng, Guanyin Huang, Xuefei Liu

|Apr 17, 2024
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial.

Ying Chen, Wen-Xia Li, Jia-Hua Wu

|May 20, 2022
The Predictive Effect of the 8th AJCC Pathological Prognostic Staging on the Benefit of Postmastectomy Radiotherapy in N2/N3 Breast Cancer.

Shi-Ping Yang, Ping Zhou, Chen-Lu Lian

|Mar 20, 2021
Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.

Jian Lei, Zhen-Yu He, Jun Wang

Pageof 2

Frequent Collaborators

3 joint publications

Yixin Cheng

2 joint publications

San-Gang Wu

2 joint publications

Siqi Chen

2 joint publications

Xuefei Liu